LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

The world’s first plant for the production of 1,4 bio-butanediol from renewable resources

18/09/2024

CASE STUDY

Submission from Assobiotec

The innovation.

1,4, Butanediol is a chemical intermediate used for a wide range of applications, including industrial processes (as a solvent) and the manufacture of diverse products including textiles, electronics, automotive and consumer goods as used in the biopolymer sector. Traditionally produced through chemical processes, the development of a biotechnology-derived process now enables its production with a 50% reduction in greenhouse gas emissions. This is a significant shift towards biotechnology within the production of bioplastics and biochemicals.

In 2016, the world’s first industrial scale plant was developed which integrated a biorefinery into existing chemical processes to produce 1,4 BDO directly from sugars, enabling the significant reduction in greenhouses gases from biotechnology-driven process. The plant can produce up to 30,000 tons per year and is a starting point for further integration of feedstock supplies (raw materials for fuel or production) for manufacturing.

The benefits.

The use of biobutanediol allows the reduction of the net Global Warming Potential “Cradle to gate” by 50% in terms of CO2 equivalent emissions, compared to the fossil alternative. The delta has been determined as the difference between the carbon footprint profile of 1,4 bio-BDO (ISO 14067:2018 certified) and the carbon footprints of fossil BDO available in literature, reflecting the most representative process technology.

Moreover, the plant is designed to reuse by-products for its own energy purpose, optimizing the whole life-cycle process. In 2020, the anaerobic digester started the first biogas production from industrial waste consisting of thermally inactivated bacteria and their residues. By introducing an additional treatment system, the biogas is now converted into biomethane and fed into the national network, allowing to further increase the plant’s efficiency.

 

Additional materials:

Mater-Biotech: The development of innovative industrial biotechnology processes complete our integrated biorefineries in local area

The world's first plant for the production of 1,4 bio-butanediol from renewable resources


Download

Share
Communications Team
Communications Team

Related posts

14/11/2025

Vial joins EuropaBio: Reimagining Drug Development with Hyper-Scalable Biotech


Read more
12/11/2025

EuropaBio response to the EU Biotech Act public consultation


Read more
05/11/2025

EuropaBio recommendations for the Circular Economy Act


Read more

Important links

  • Vial joins EuropaBio: Reimagining Drug Development with Hyper-Scalable Biotech
  • EuropaBio response to the EU Biotech Act public consultation

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.